NOVARTIND2,420.80

Novartis India Limited

· Pharma & Health
₹ CrorePeersBPLPHARMAJENBURPHKPLMAKERSLPARNAXLABSGRLSHUKRAPHARSUNLOC
View
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
Non-current Assets
+ Property, Plant & Equipment19.31.71.0
+ Other Non-current Financial Assets2.51.1
+ Deferred Tax Assets15.815.415.5
+ Other Non-current Assets89.1
Total Non-current Assets305.6202.0
Current Assets
+ Inventories54.744.941.1
+ Trade Receivables36.241.540.1
+ Cash & Cash Equivalents19.445.052.1
+ Other Bank Balances536.5551.1
+ Other Current Financial Assets13.92.20.9
Current Financial Assets606.0639.7
+ Other Current Assets16.616.015.6
Total Current Assets677.3699.3745.8
Total Assets982.9924.9947.8
Equity
+ Equity Share Capital12.312.312.3
+ Other Equity / Reserves763.3732.5772.6
Equity — Owners of Parent775.7785.0
Total Equity775.7744.8785.0
Liabilities
+ Other Non-current Financial Liab7.80.2
+ Provisions — Non-current22.617.4
Non-current Liabilities47.820.8
+ Borrowings — Current1.40.0
+ Trade Payables59.761.651.5
+ Other Current Financial Liab30.10.2
+ Provisions — Current55.717.652.3
+ Current Tax Liabilities6.17.513.4
+ Other Current Liabilities3.85.03.4
Current Liabilities159.5157.2142.1
Total Liabilities207.3162.9
Total Equity & Liabilities982.9924.9947.8
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY25 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 85%.